Clinical Trial Update: Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating polatuzumab vedotin in combination with chemotherapy for Richter syndrome and chronic lymphocytic leukemia; recruitment is ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Richter Syndrome

Drugs mentioned

• Polivy (polatuzumab vedotin) (polatuzumab vedotin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Richter Syndrome, Chronic Lymphocytic Leukemia | Phase 2 | Status: RECRUITING